Academics, Public Interest Groups Warn About "Siloing" Of Gene Test Info
This article was originally published in The Pink Sheet Daily
Government overreach could inappropriately deny people access to information about their own bodies, create racial disparities and even be counter to congressional intent, they say.
You may also be interested in...
Often-overlooked DNA segments may offer Dx value
Citing the need to prove that direct-to-consumer genetic assays are analytically and clinically accurate, CDRH sent letters to five genetic testing firms June 10 requesting pre-market submissions for the companies' already-marketed services
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.